Drug Type Small molecule drug |
Synonyms Cmpd 3 |
Target |
Action inhibitors |
Mechanism SIK1 inhibitors(salt inducible kinase 1 inhibitors), SIK2 inhibitors(Serine/threonine-protein kinase SIK2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Inflammatory Bowel Diseases | Preclinical | United States | 26 Dec 2023 | |
| Inflammatory Bowel Diseases | Preclinical | - | 26 Dec 2023 |





